Professor Kari Remes - UTU Research Portal

Kari Remes
Professor

- Docent,
Faculty of Medicine (University of Turku)

kari.remes@utu.fi

	Publications full list.pdf
	CV Remes Kari.pdf

Areas of expertise

Clinical haematology; Bone marrow transplantation

Teaching

Hematologian luennointi ja seminaarit (C6 ja C11). Hematologian ryhmäopetus (C6). Hematologisten syventävien opinnäytteiden ohjaus.

Publications

1 of 3

Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group (2024)
- Journal of patient-reported outcomes
Nielsen Lene Kongsgaard, Schjesvold Fredrik, Moeller Soeren, Guldbrandsen Nina, Hansson Markus, Remes Kari, Peceliunas Valdas, Abildgaard Niels, Gregersen Henrik, King Madeleine T.
(A1 Refereed original research article in a scientific journal)
Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients (2024)
- Bone Marrow Transplantation
Brune, Mats; Kiss, Thomas; Anderson, Harald; Nicklasson, Malin; Delage, Robert; Finke, Jürgen; Gedde-Dahl, Tobias; Hébert, Josée; Höglund, Martin; Kaare, Ain; Lazarevic, Vladimir; Möllgård, Lars; Remes, Kari; Ritchie, David; Spyridonidis, Alexandros; Sabloff, Mitchell; Spearing, Ruth; Wallhult, Elisabeth; Ljungman, Per
(A1 Refereed original research article in a scientific journal)
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group (2022)
- European Journal of Haematology
Gregersen Henrik, Peceliunas Valdas, Remes Kari, Schjesvold Fredrik, Abildgaard Niels, Nahi Hareth, Andersen Niels Frost, Vangsted Annette Juul, Klausen Tobias Wirenfeldt, Helleberg Carsten, Carlson Kristina, Frolund Ulf Christian, Axelsson Per, Stromberg Olga, Blimark Cecilie Hveding, Crafoord Jacob, Tsykunova Galina, Eshoj Henrik Rode, Waage Anders, Hansson Markus, Gulbrandsen Nina
(A1 Refereed original research article in a scientific journal)
Luovuttajan lymfosyytti-infuusiot allogeenisen kantasolujen siirron jälkihoidossa (2022)
- Duodecim
Peltola Pauliina, Remes Kari, Ollila Helena, Putkonen Mervi, Itälä-Remes Maija
(A1 Refereed original research article in a scientific journal)
A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide (2020)
- Clinical Lymphoma, Myeloma and Leukemia
Barbara Gamberi, Christian Berthou, Miguel Hernandez, Gianpietro Semenzato, Eleni Tholouli, Roman Hájek, Jo Caers, Meletios Dimopoulos, Monique C. Minnema, Bjorn Andreasson, Joana Parreira, Gerard Crotty, Kari Remes, Elisabeth Kueenburg, Barbara Rosettani, Antonia Di Micco, Sarah Peters, Pamela Bacon, Igor Wolfgang Blau
(A1 Refereed original research article in a scientific journal)
Allogeeniset kantasolusiirrot soveltuvat iäkkäillekin (2018)
- Duodecim
Jokela S, Itälä-Remes M, Salmenniemi U, Putkonen M, Kauppila M, Salmi T, Salomäki S, Remes K
(A1 Refereed original research article in a scientific journal)
Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013 (2018)
- PLoS ONE
Kari Remes, Pekka Anttila, Raija silvennoinen, Mervi Putkonen, Hanna Ollikainen, Venla Terävä, Marjatta Sinisalo, Kristiina Kananen, Frida Schain, Päivi Castren-Kortegangas, Tiina M Järvinen, Marta Pisini, Felix Wahl, Tricia Dixon
(A1 Refereed original research article in a scientific journal)
Severe neutropenia after rituximab-treatment of multiple sclerosis (2018)
- Multiple Sclerosis and Related Disorders
Eero Rissanen, Kari Remes, Laura Airas
(A1 Refereed original research article in a scientific journal)
Geenimutaatioon kohdennettu hoito parantaa akuutin myelooisen leukemian (AML) hoitotuloksia (2017)
- Duodecim
Kari Remes
(Other publication)
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia (2017)
- Leukemia
Kontro M, Kumar A, Majumder MM, Eldfors S, Parsons A, Pemovska T, Saarela J, Yadav B, Malani D, Fløisand Y, Höglund M, Remes K, Gjertsen BT, Kallioniemi O, Wennerberg K, Heckman CA, Porkka K
(A1 Refereed original research article in a scientific journal)
Mikä hoidoksi refraktaarissa AML:ssä? (2017)
- Duodecim
Kari Remes
(Other publication)
Aikuisten akuutin myelooisen leukemian hoito (2016)
- Duodecim
Järvenpää J, Itälä-Remes M, Kauko T., Salmenniemi U, Kauppila M, Putkonen M, Salmi T, Remes K
(A1 Refereed original research article in a scientific journal)
A Prospective Randomized Trial Comparing Cyclosporine/Methotrexate And Tacrolimus/Sirolimus As Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation (2016)
- Haematologica
Törlén J, Ringdén O, Garming-Legert K, Ljungman P, Winiarski J, Remes K, Itälä-Remes M, Remberger M, Mattsson J
(A1 Refereed original research article in a scientific journal)
A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma (2016)
- Bone Marrow Transplantation
Ollikainen H, Terävä V, Kutila A, Launonen K, Räsänen A, Sikiö A, Suominen M, Bazia P, Kananen K, Selander T, Kuittinen T., Remes K, Jantunen E
(A1 Refereed original research article in a scientific journal)
Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison (2016)
- Transfusion
Valtola J, Silvennoinen R, Ropponen A, Siitonen T, Saily M, Sankelo M, Terava V, Putkonen M, Kuittinen T, Pelkonen J, Mantymaa P, Remes K, Varmavuo V, Jantunen E
(A1 Refereed original research article in a scientific journal)
Cost analysis of a randomized stem cell mobilization study in multiple myeloma (2016)
- Annals of Hematology
Varmavuo V, Silvennoinen R, Anttila P, Saily M, Sankelo M, Putkonen M, Ahonen J, Mahlamaki E, Mantymaa P, Savolainen ER, Remes K, Jantunen E
(A1 Refereed original research article in a scientific journal)
Prognostic Comparison Between ISS and R-ISS in Real-Life Setting of Myeloma Patients: An Example of Utilization of Electronic Biobank Database (2016)
- Blood
Samu Kurki, Klaus Tamminen, Tatu Miettinen, Kari Remes
(Other publication)
Trombosyyttisiirrot verenvuotojen ehkäisyssä (2016)
- Duodecim
Ilmakunnas M, Remes K, Hiippala S, Mäkisalo H, åberg F
(A2 Refereed review article in a scientific journal )
Application of sensitive alleleSEQR chimerism PCR from peripheral blood in allografted AML/MDS patients treated with pre-empitive post-transplant immunomudolation (2015)
- Leukemia
Salmenniemi U, Kairisto V, Leino J, Putkonen M, Kauppila M, Salmi T, Oksman M, Remes K, Itälä-Remes M
(B1 Non-refereed article in a scientific journal)
Autologous stem cell transplantation versus novel drugs or conventional chemothrerapy for patients with relapsed multiple myeloma after previous ASCT (2015)
- Bone Marrow Transplantation
Grövdal M, Nahi H, Gahrton G, Liwing J, Waage A, Abildgaard N, Pedersen PT, Hammerstöm J, Laaksonen A, Bazia P, Terava V. Ollikainen H, Silvennoinen R, Putkonen M, Anttila P, Porkka K, Remes K
(A1 Refereed original research article in a scientific journal)